Imanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand Posted on June 30, 2017May 25, 2020 by dev_team
Cerveau Technologies, Inc. Announces Collaboration with NYU Langone Medical Center Posted on June 26, 2017May 25, 2020 by dev_team
Cerveau Technologies, Inc. Announces FDA Acceptance of Investigational New Drug (IND) for Tau Imaging Agent MK-6240 Posted on June 16, 2017May 25, 2020 by dev_team
Collaborators Login